AI for Pharma Market Access” Course Launches in 2025
The AI for Pharma Market Access Course is poised to become a transformative learning experience for ...
April 9 - June 6London Biotechnology Show 2025
Accelerating Medical Biotechnology Globally The London Biotechnology Show 2025 is scheduled for June...
June 18 - June 19ISPOR Europe 2025
The Leading Global Conference for Health Economics and Outcomes Research ISPOR Europe 2025, the prem...
November 9 - November 12
Patients with chronic kidney disease (CKD) and type 2 diabetes have a promising new treatment option as the Phase II CONFIDENCE study reveals substantial improvements in kidney function when...
A recent clinical trial investigating tinurilimab, a new antibody treatment for advanced solid tumors, has been halted due to significant safety issues and lack of efficacy. The study, which...
Alcohol-related liver disease (ALD) continues to claim lives globally, presenting significant challenges to both individuals and healthcare systems. Recent insights highlight the critical role of public health strategies in...
Bringing together leading health professionals, the ARTEMIS conference in 2022 focused on combating invasive meningococcal disease (IMD) through enhanced vaccination efforts across the United States.Current Landscape and ChallengesAdolescents and...
Upcoming Meetings
Pharmacoeconomics
Latest NewsLatest
Combined Therapy Shows Significant Kidney Benefits in Diabetes Patients
Patients with chronic kidney disease (CKD) and type 2 diabetes have a promising new treatment option as the Phase II CONFIDENCE study reveals substantial...
New Study Highlights Safer Anticoagulant Options for the Elderly with Atrial Fibrillation
A recent global registry study sheds light on the heightened risks faced by elderly patients with atrial fibrillation and underscores the advantages of newer...
US Reproductive-Aged Adults Willing to Spend $5K on IVF
A recent survey reveals that American adults of reproductive age are prepared to invest a median of $5,000 out-of-pocket for in vitro fertilization (IVF),...
Netherlands Boosts PrEP Access to Combat HIV Among MSM
The Netherlands is taking significant steps to widen access to pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM), aiming to drastically...
Scientists Develop Bayesian Strategy to Optimize Clinical Trial Populations
Advancements in personalized medicine have heightened the importance of precise population selection in clinical trials. Researchers have introduced a novel hybrid Bayesian design aimed...
Tinurilimab Trial Ends After Safety Concerns Emerge
A recent clinical trial investigating tinurilimab, a new antibody treatment for advanced solid tumors, has been halted due to significant safety issues and lack...
New Shiny App Enhances Medication Trend Analysis in Ireland
Healthcare professionals and policymakers in Ireland gain a powerful tool with the launch of RxTrends, an R-based Shiny application designed to visualize and analyze...
Paclitaxel Combinations Enhance Triple-Negative Breast Cancer Outcomes
Recent advancements in cancer treatment have spotlighted the potential of paclitaxel-based regimens in managing triple-negative breast cancer (TNBC). This comprehensive network meta-analysis investigates the...
HutchMed, Innovent Gain NDA Green Light for Advanced Kidney Cancer Therapy in China
HUTCHMED and Innovent Biologics have reached a significant milestone as China's National Medical Products Administration (NMPA) accepts their new drug application (NDA) for a...
One in Three Pregnant Women in Amhara Region Still Infected with Intestinal Parasites After Deworming
Despite receiving standard deworming treatment, a significant proportion of pregnant women in the Amhara region of Ethiopia continue to grapple with intestinal parasitic infections....
